Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/28/1997 | US5681581 Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
10/28/1997 | US5681580 Plate with embossed portion electrically contacts an electrode pattern formed in a printed circuit board |
10/28/1997 | US5681578 Mixture containing 4-aminobutyric acid, glutamine, glycine, magnesium, passion flower, primula officinalis, vitamin b6 for aiding natural inhibitory neurotransmitter system of brain |
10/28/1997 | US5681577 Multiple action cold/sinus preparations |
10/28/1997 | US5681573 Dissolving in water saturated with carbon dioxide, then freeze drying the solution yields storage stable drug for injection after regeneration |
10/28/1997 | US5681568 Device for delivery of substances and methods of use thereof |
10/28/1997 | US5681564 Therapeutic dose of aqueous slurry of activated charcoal;straw interior coated with flavor |
10/28/1997 | US5681555 Method for the treatment of bronchial asthma by parenteral administration of anionic polymers |
10/28/1997 | US5681547 Used for deodorants and antiperspirants |
10/28/1997 | US5681545 Charging aerosol container with a medicament and propellent selected from 1,1,1,2-tetrafluoroethane free of chlorofluorocarbons, dispersing said medicine, suitable for delivery to lungs by inhalation |
10/28/1997 | US5681413 Materials handling of lamination, transferring the active material drug on carrier sheet, conveying, dividing with different motion, different speed and direction |
10/28/1997 | US5681382 Mixtures of hydroxypropyl methyl cellulose and/or methyl cellulose having controlled particle sizes with pigments and plasticizers, for coating drug tablets |
10/28/1997 | CA2036038C Hot-melt silicone pressure sensitive adhesive composition and related methods and articles |
10/25/1997 | CA2199920A1 Acetylsalicylic acid-containing alcoholic solutions for percutaneous employment, their use for antithrombotic therapy, and a pharmaceutical |
10/24/1997 | CA2203222A1 Controlled-release pharmaceutical compositions |
10/24/1997 | CA2194428A1 Controlled release of steroids from sugar coatings |
10/23/1997 | WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
10/23/1997 | WO1997039107A2 Methods for increasing the maturation of cells |
10/23/1997 | WO1997039050A1 Sustained release heterodisperse hydrogel systems - amorphous drugs |
10/23/1997 | WO1997039019A1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
10/23/1997 | WO1997039004A1 Organo phosphorous compounds |
10/23/1997 | WO1997038960A1 D-mannitol and its preparation |
10/23/1997 | WO1997038731A1 Immunoliposomes that optimize internalization into target cells |
10/23/1997 | WO1997038729A1 In vivo gene transfer methods for wound healing |
10/23/1997 | WO1997038726A2 Hydrophobic carbomer complex compositions |
10/23/1997 | WO1997038707A1 Method and device for delivery of apoptosis-inducing molecules |
10/23/1997 | WO1997038699A2 Use of alkylaryl polyether alcohol polymers for the treatment of chronic pulmonary inflammation |
10/23/1997 | WO1997038698A1 Methods for treating middle and inner ear disorders |
10/23/1997 | WO1997038693A1 Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions |
10/23/1997 | WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate |
10/23/1997 | WO1997038687A1 Buccal, non-polar spray for nitroglycerin |
10/23/1997 | WO1997038679A2 Fast disintegrating oral dosage form |
10/23/1997 | WO1997038678A1 Hydrolyzed cellulose granulations for pharmaceuticals |
10/23/1997 | WO1997038677A2 Freeze-dried liposome delivery system for application of skin treatment agents |
10/23/1997 | WO1997038676A1 Bioerodable polymeric adhesives for tissue repair |
10/23/1997 | WO1997038675A1 New pharmaceutical composition with anaesthetic effect |
10/23/1997 | WO1997038674A1 Ophthalmic compound with extended dwell time on the eye |
10/23/1997 | WO1997038668A1 Local delivery of chemotherapeutic agents for treatment of periodontal disease |
10/23/1997 | WO1997038663A2 Buccal, non-polar spray or capsule |
10/23/1997 | WO1997038662A2 Buccal polar spray or capsule |
10/23/1997 | WO1997038648A1 Iontophoretic material |
10/23/1997 | WO1997038579A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no) |
10/23/1997 | WO1997034586A3 Device and method for treating ophthalmic diseases |
10/23/1997 | WO1997033632A3 Alginate containing antimicrobial composition |
10/23/1997 | WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration |
10/23/1997 | DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids |
10/23/1997 | DE19615777A1 Verwendung von Milschsäureestern Use of Milschsäureestern |
10/23/1997 | DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis |
10/23/1997 | DE19615418A1 Polyol-Zusammensetzung Polyol composition |
10/23/1997 | CA2254823A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no) |
10/23/1997 | CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
10/23/1997 | CA2251849A1 Hydrophobic carbomer complex compositions |
10/23/1997 | CA2251543A1 Novel cationic cholesteryl derivatives containing cyclic polar groups |
10/23/1997 | CA2251384A1 Use of alkylaryl polyether alcohol polymers for the inhibition of nuclear transcription factor nf-xb |
10/23/1997 | CA2251092A1 D-mannitol and its preparation |
10/22/1997 | EP0801950A1 Pharmaceutical composition for diuretic and antihypertensive oral therapy comprising furosemide and tromethamine |
10/22/1997 | EP0801948A1 Ophthalmic composition having prolonged residence time in the eye |
10/22/1997 | EP0801676A2 New artificial tissue, method for the production and the use thereof |
10/22/1997 | EP0801656A1 Induction of cytotoxic t-lymphocyte responses |
10/22/1997 | EP0801573A1 A stabilized pharmaceutical formulation comprising a growth hormone and leu-his-leu |
10/22/1997 | EP0801571A1 Soluble 2-chloro-2'-deoxyadenosine formulations |
10/22/1997 | EP0801562A1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
10/22/1997 | EP0801561A2 Composition and methods for transdermal delivery of acid-labile drugs |
10/22/1997 | EP0801560A1 A controlled release drug suspension delivery device |
10/22/1997 | EP0801559A1 ORAL DOSAGE-FORMS CONTAINING A $g(b)-LACTAM ANTIBIOTIC |
10/22/1997 | EP0801558A1 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays |
10/22/1997 | EP0801557A2 LIPOSOME FORMULATIONS OF 5$g(b) STEROIDS |
10/22/1997 | EP0801554A1 Formulations and methods for reducing skin irritation |
10/22/1997 | EP0697858B1 Nasal drug delivery composition containing nicotine |
10/22/1997 | EP0580860B1 Method of manufacturing solid dispersion |
10/22/1997 | CN1162971A Process for stabilizng gelatin products |
10/22/1997 | CN1162921A A storage stable water solution for infusion containing a thrombin inhibitor |
10/22/1997 | CN1162917A Enteric film coating compositions, method of coating therewith, and coated forms |
10/22/1997 | CN1162486A Jieyangting ointment for scabies |
10/22/1997 | CN1162483A Silk ointment for promoting the union of wounded skin |
10/22/1997 | CN1162479A Powder for curing gastritis and preparation thereof |
10/22/1997 | CN1162474A Folium ginkgo injection and preparation thereof |
10/22/1997 | CN1162472A Medicine for psoriasis |
10/22/1997 | CN1162471A Instant powder to invigorate the function of spleen and preparation thereof |
10/22/1997 | CN1162459A High performance and quick effective skin penetrating and slow releasing Chinese medical paste and preparations |
10/22/1997 | CN1162453A Kouyangning lozenge |
10/22/1997 | CN1162448A Prescription for curing gonorrhea and preparation thereof |
10/22/1997 | CN1162447A Preparation for central nerves of muscle |
10/21/1997 | US5679713 Pharmaceutical composition containing carbachol and other cholinergic substances |
10/21/1997 | US5679691 Use of a spin trap in a cosmetic or dermatological composition |
10/21/1997 | US5679690 Solution consists of antithrombin argatroban, micelle forming agents such as cholic acid derivatives and one or more lipids |
10/21/1997 | US5679685 Accelerated release composition containing bromocriptine |
10/21/1997 | US5679675 Bactericides |
10/21/1997 | US5679665 Pharmaceutical formulation comprised of polymyxintrimethoprim and an anti-inflammatory drug for ophthalmic and otic topical use |
10/21/1997 | US5679660 Pharmaceutical composition comprising diclofenac and cyclodextrin |
10/21/1997 | US5679647 Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
10/21/1997 | US5679459 Perfluorinated amphiphilic phosphorous compounds: liposomal compositions |
10/21/1997 | US5679406 Tablet dipping systems for apparatus for gelatin coating tablets |
10/21/1997 | US5679398 Chewing gum |
10/21/1997 | US5679394 Adjunct administration of particulate therapeutic or diagnostic agent and dwell-time enhancing agent |
10/21/1997 | US5679377 Protein microspheres and methods of using them |
10/21/1997 | US5679376 Diphenoxylate, loperamide, and derivatives as treatment for gastrointestinal disorders |
10/21/1997 | US5679374 Dispersion of lipid vesicles capable of penetrating into layers of skin and containing antimicrobial agents, n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidyl)-n-dimethyl-n-hydro xyethylammonium iodide, antiinflammatory agents, retinol |
10/21/1997 | US5679373 Process of assembling a transdermal patch incorporating a polymer film incorporated with an active agent |
10/21/1997 | US5679360 Substance P antagonist for the treatment of lichens, prurigo, pruritus |